Page last updated: 2024-10-24

orexin receptor activity

Definition

Target type: molecularfunction

Combining with orexin to initiate a change in cell activity. [GOC:ai]

Orexin receptors, also known as hypocretin receptors, are G protein-coupled receptors that play a crucial role in regulating arousal, wakefulness, and appetite. They are activated by the neuropeptides orexin A and orexin B, which are produced in the hypothalamus. There are two main types of orexin receptors: orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R). Both receptors are expressed throughout the brain and in peripheral tissues, but they have distinct distributions and signaling properties.

**OX1R** is primarily expressed in the lateral hypothalamus, the perifornical area, the paraventricular nucleus, and the dorsal raphe nucleus. It is also found in the amygdala, hippocampus, and cortex. Activation of OX1R leads to the stimulation of the Gq/11 signaling pathway, resulting in the activation of phospholipase C (PLC), which in turn hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3). DAG activates protein kinase C (PKC), while IP3 mobilizes intracellular calcium. This cascade of events leads to the phosphorylation of downstream signaling molecules, ultimately resulting in increased neuronal excitability, arousal, and wakefulness.

**OX2R** is more widely distributed than OX1R, with high expression in the locus coeruleus, the ventrolateral periaqueductal gray, the dorsal raphe nucleus, and the substantia nigra. It also has a significant presence in the amygdala, hippocampus, and cortex. Activation of OX2R triggers the Gαs signaling pathway, leading to the stimulation of adenylyl cyclase and the subsequent production of cyclic adenosine monophosphate (cAMP). cAMP activates protein kinase A (PKA), which then phosphorylates various downstream targets, resulting in a variety of cellular effects, including the modulation of synaptic plasticity, neurotransmitter release, and gene expression.

**Overall, orexin receptor activity is essential for maintaining normal sleep-wake cycles, regulating energy homeostasis, and controlling appetite. Dysregulation of orexin signaling has been implicated in various neurological and psychiatric disorders, including narcolepsy, obesity, and addiction. Therefore, understanding the molecular function of orexin receptors is crucial for developing effective therapies for these conditions.**'
"

Proteins (2)

ProteinDefinitionTaxonomy
Orexin receptor type 2An orexin receptor type 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43614]Homo sapiens (human)
Orexin receptor type 1An orexin/hypocretin receptor type 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43613]Homo sapiens (human)

Compounds (16)

CompoundDefinitionClassesRoles
sr141716amidopiperidine;
carbohydrazide;
dichlorobenzene;
monochlorobenzenes;
pyrazoles
anti-obesity agent;
appetite depressant;
CB1 receptor antagonist
sb 408124SB 408124: a hypocretin receptor type 1 (HcrtR1) antagonistorganohalogen compound;
quinolines
sb 334867-a1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea: selective OX1 receptor antagonistnaphthyridine derivative
nalfurafine hydrochloride
jnj 10397049JNJ 10397049: a selective orexin receptor-2 antagonist
sb674042SB674042: nonpeptide antagonist to the human orexin-1 receptor; structure in first source
tcs ox2 29
almorexantalmorexant: a dual orexin receptor antagonist for treatment of insomniaisoquinolines
suvorexantsuvorexant : An aromatic amide obtained by formal condensation of the carboxy group of 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid with the secondary amino group of 5-chloro-2-[(5R)-5-methyl-1,4-diazepan-1-yl]-1,3-benzoxazole. An orexin receptor antagonist used for the management of insomnia.

suvorexant: an orexin receptor antagonist; structure in first source
1,3-benzoxazoles;
aromatic amide;
diazepine;
organochlorine compound;
triazoles
central nervous system depressant;
orexin receptor antagonist
mk-6096MK-6096: antagonist of orexin receptors 1 and 2; structure in first source
sb 649868N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide: antagonist of both orexin 1 and orexin 2 receptors; for treating insomnia; structure in first source
act-462206ACT-462206: an antagonist of both orexin 1 and oxexin 2 receptors; structure in first source
oroxin b
gsk 1059865
act-335827
orexin-a